255 related articles for article (PubMed ID: 10723979)
1. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch.
Blockmans D; Stroobants S; Maes A; Mortelmans L
Am J Med; 2000 Feb; 108(3):246-9. PubMed ID: 10723979
[No Abstract] [Full Text] [Related]
2. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.
Blockmans D; Maes A; Stroobants S; Nuyts J; Bormans G; Knockaert D; Bobbaers H; Mortelmans L
Rheumatology (Oxford); 1999 May; 38(5):444-7. PubMed ID: 10371283
[TBL] [Abstract][Full Text] [Related]
3. Polymyalgia rheumatica and giant-cell arteritis.
Blockmans DE
N Engl J Med; 2002 Dec; 347(25):2083-5; author reply 2083-5. PubMed ID: 12494942
[No Abstract] [Full Text] [Related]
4. FDG positron emission tomography of giant cell arteritis with polymyalgia rheumatica.
Shikino K; Ikusaka M; Shimada F
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25762574
[No Abstract] [Full Text] [Related]
5. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with polymyalgia rheumatica: Screening for vasculitis.
Arévalo Ruales K; Negueroles Albuixech R; Loaiza Gongora J; Grau García E; Ivorra Cortés J; Román Ivorra JA
Reumatol Clin (Engl Ed); 2020; 16(1):38-41. PubMed ID: 29550251
[TBL] [Abstract][Full Text] [Related]
6. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study.
Moosig F; Czech N; Mehl C; Henze E; Zeuner RA; Kneba M; Schröder JO
Ann Rheum Dis; 2004 Jul; 63(7):870-3. PubMed ID: 15194587
[TBL] [Abstract][Full Text] [Related]
7. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
Soriano A; Pazzola G; Boiardi L; Casali M; Muratore F; Pipitone N; Catanoso M; Aldigeri R; Cimino L; Versari A; Salvarani C
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):99-106. PubMed ID: 29799393
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography: the ideal tool in polymyalgia rheumatica?
Wendling D; Blagosklonov O; Boulahdour H; Prati C
Joint Bone Spine; 2014 Oct; 81(5):381-3. PubMed ID: 24962975
[No Abstract] [Full Text] [Related]
10. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
11. Cranial giant cell arteritis evolving into early large-vessel vasculitis.
Ghinoi A; Pipitone N; Nicolini A; Salvarani C
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S97-100. PubMed ID: 18799063
[No Abstract] [Full Text] [Related]
12. High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography.
Cimmino MA; Camellino D; Paparo F; Morbelli S; Massollo M; Cutolo M; Sambuceti G
Rheumatology (Oxford); 2013 Oct; 52(10):1865-72. PubMed ID: 23850896
[TBL] [Abstract][Full Text] [Related]
13. Where does polymyalgia rheumatica end and giant cell arteritis begin? Lessons from positron emission tomography studies.
Blockmans D
Acta Clin Belg; 2012; 67(6):389-93. PubMed ID: 23340142
[No Abstract] [Full Text] [Related]
14. The natural history of asymptomatic positron emission tomography: positive giant cell arteritis after a case of self-limiting polymyalgia rheumatica.
Yamashita H; Inoue M; Takahashi Y; Kano T; Mimori A
Mod Rheumatol; 2012 Nov; 22(6):942-6. PubMed ID: 22710835
[No Abstract] [Full Text] [Related]
15. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis.
Park JR; Jones JG; Hazleman BL
Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213
[TBL] [Abstract][Full Text] [Related]
16. Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review.
Loricera J; Blanco R; Hernández JL; Carril JM; Martínez-Rodríguez I; Canga A; Peiró E; Alonso-Gutiérrez J; Calvo-Río V; Ortiz-Sanjuán F; Mata C; Pina T; González-Vela MC; Martínez-Amador N; González-Gay MA
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-19-31. PubMed ID: 25437450
[TBL] [Abstract][Full Text] [Related]
17. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis.
Both M; Ahmadi-Simab K; Reuter M; Dourvos O; Fritzer E; Ullrich S; Gross WL; Heller M; Bähre M
Ann Rheum Dis; 2008 Jul; 67(7):1030-3. PubMed ID: 18223265
[TBL] [Abstract][Full Text] [Related]
18. Microheterogeneity of alpha 1-antichymotrypsin in the management of giant-cell arteritis and polymyalgia rheumatica.
Hachulla E; Laine A; Hayem A
Clin Sci (Lond); 1990 Jun; 78(6):557-64. PubMed ID: 2165887
[TBL] [Abstract][Full Text] [Related]
19. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica.
Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
